Clinical Glutathione

Brand IP Statement(s) re: (c), (TM), (SM)

Sublinthion Patented Protected System

Formulation re: Other

Proven stability 230% improvement in blood GSH/GSSG ratio

FDA Statement of Identity

Dietary Supplement

Formulation re: Vegetarian/Vegan

Vegan

Formulation re: Other

Sublinthion is a unique, protected, patented process from France. In a human study, Clinical Glutathione with Sublinthion improved the reduced glutathione vs. oxidized ratios in the body by 230%.

Formulation re: Does NOT Contain

No sugar, salt, wheat, gluten, corn, soy, dairy products, artificial coloring, or artificial preservatives.

Suggested/Recommended/Usage/Directions

Recommendations: Take 2 tablets daily. One tablet in A.M. and one tablet in the P.M., or as recommended by your healthcare practitioner. Tablet should be held in mouth and allowed to dissolve before swallowing for optimal results.

Precautions re: Pregnant or Nursing or Prescription Medications

If pregnant or nursing, consult a healthcare practitioner before using.

Formulation re: Other

This formula has been clinically studied.

Brand IP Statement(s) re: (c), (TM), (SM)

French Patent #FR2972327

General Statements: All Other Content

Blood ratios of active glutathione to oxidized glutathione between day 1 and day 21 after supplementation.